2018 American Transplant Congress
Outcomes of ABO Non-Identical Pancreas Transplant
Indiana University School of Medicine, Indianapolis.
A data review of all pancreas transplants since 2003 (n=606) at our institution revealed 41 recipients of a non-identical ABO donor pancreas. They were matched…2018 American Transplant Congress
Outcomes after Cardiac Transplantation for Adult Congenital Heart Disease in the Modern Era
Background: More patients with congenital heart disease (CHD) are surviving into adulthood and require heart transplantation. These patients historically experienced worse survival early after transplantation.…2018 American Transplant Congress
Benefit of Patient Portal Usage in Non-High Risk Kidney Transplant Recipients
Surgery, Alpert Medical School of Brown University, Providence, RI.
Background: With widespread adoption of EHR (electronic health record), patients have access to a patient portal where they can view and thereby help monitor their…2018 American Transplant Congress
DSA Plus TCMR Leads to Poor Outcomes in Renal Allograft Recipients and This is Markedly Exacerbated by Non-Adherence
Starzl Transplant Institute, University of Pittsburgh, Pittsburgh.
Post-transplant DSA is strongly associated with poor renal allograft outcomes but has limited predictive value. In this prospective study we aimed to risk-stratify patients with…2018 American Transplant Congress
De Novo Use of Extended Released Tacrolimus (Meltdose, EnvasusR)) after OLT – Does the Colonic Resorption Influences the Outcome?
Department of Transplantation, Medical University of Vienna, Vienna, Austria.
Introduction: Immunosuppression after OLT has reached a quite high standard with an excellent evidence base. However, there is still a lack of data for the…2018 American Transplant Congress
Nontuberculous Mycobacteria in Lung Transplant Recipients: Prevalence, Risk Factors and Impact on Survival and Graft Function
University of Alberta, Edmonton, Canada.
BACKGROUND. Nontuberculous mycobacteria (NTM) may colonize or infect lung transplant patients. Due to differences in populations studied and geographical diversity of NTM, risk factors for…2018 American Transplant Congress
Donor Acute Kidney Injury Does Not Affect Fibrosis on 1 Year Post-Transplant Kidney Biopsy
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA.
PurposeThe use of kidneys from deceased donors with acute kidney injury (AKI) at the time of donation is a potential method by which to expand…2018 American Transplant Congress
Complications and QoL after Living Donor Hepatectomy: Analysis of 176 Cases at a Single Center
Department of Surgery, University of Minnesota, Minneapolis.
Background: Living liver donation is one of the most selfless and humane acts a person can perform. Few single-center reports have been published specifically evaluating…2018 American Transplant Congress
Metformin Use after Kidney Transplantation: A Safe Option in Carefully Selected Patients
Recent guidelines support metformin as a therapeutic option in diabetic patients with mild to moderate renal insufficiency. The frequency and outcomes of metformin use in…2018 American Transplant Congress
Mortality and ESRD in Older Live Kidney Donors with Hypertension
1Johns Hopkins, Baltimore; 2University of Colorado, Aurora; 3SRTR, Minneapolis.
Hypertension in otherwise healthy screened older kidney donor candidates is viewed as relatively benign, yet the long-term outcome of older donors with hypertension is unclear.…
- « Previous Page
- 1
- …
- 89
- 90
- 91
- 92
- 93
- …
- 155
- Next Page »